Clinical trials
Treatment clinical trials
Below are recruiting treatment clinical trials, each written for real people, not researchers. We’re tracking 8,313 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07023588RecruitingPhase 2
Optimizing AML treatment based on early response
This trial tests if adjusting chemotherapy based on early signs of leukemia can improve outcomes for people newly diagnosed with acute myeloid leukemia (AML). It might be a good fit if you are starting treatment and have a certain level of leukemia cells in your blood after a few days of therapy.
Changchun, JilinAges 18 years+ - NCT07016165RecruitingPhase 4
Comparing two antibiotics for fever with low white blood cells in children with blood cancer
This trial compares two antibiotics, ciprofloxacin and ceftazidime, to see which works better for treating fever in children with blood cancer who have a high risk of infection due to low white blood cells. The goal is to find the best treatment to help your child recover faster.
Sleman, DI YogyakartaAges Up to 18 years - NCT07019298Recruiting
Comparing dental filling methods for root canals
This trial studies different ways to fill a root canal after treatment to see which works best. It may help if you have a tooth with an infected or dying nerve.
Madrid, SpainAges 18 years+ - NCT07014293Recruiting
Building resilience in early lymphoma survivors
This study looks at ways to help people feel stronger and cope better after finishing lymphoma treatment. If your lymphoma is under control, you may join to learn skills that improve your emotional well-being.
Boston, MassachusettsAges 18 years+ - NCT07020065RecruitingPhase 2
Reduced chemo plus immunotherapy vs immunotherapy alone for older lung cancer patients
This trial tests whether a reduced dose of chemotherapy plus an immunotherapy drug (Cemiplimab) works better than Cemiplimab alone for older or frail patients with advanced lung cancer whose PD-L1 level is below 50%. It aims to find a gentler but effective treatment option.
Fribourg, Villars-sur-GlâneAges 70 years+ - NCT07022223RecruitingPhase 2
Orelabrutinib plus rituximab for first treatment of marginal zone lymphoma
This trial tests a combination of two targeted drugs, orelabrutinib and rituximab, as the first systemic treatment for marginal zone lymphoma. If you have not yet had chemotherapy for your lymphoma and meet certain health criteria, you may be able to join.
Hangzhou, ZhejiangAges 18 years+ - NCT07017829RecruitingPhase 2
Combination therapy for STK11-mutant lung cancer
This trial tests a new drug (GT103) combined with the approved immunotherapy drug pembrolizumab for people with advanced lung cancer that has a specific genetic change (STK11). The goal is to see if adding GT103 helps control the cancer better than pembrolizumab alone.
Buffalo, New YorkAges 18 years+ - NCT07018037Recruiting
TTV levels during first immunotherapy for kidney cancer
This study looks at whether a virus called TTV (torque teno virus) in the blood can help predict how well immunotherapy works for advanced kidney cancer. If you have clear cell renal cell carcinoma that has spread and are about to start your first immunotherapy, you may be able to join.
Rome, RomeAges 18 years+ - NCT07018947RecruitingPhase 2
Atezolizumab and bevacizumab before and after surgery for liver cancer
This trial tests whether adding two drugs (atezolizumab and bevacizumab) before and after surgery can lower the chance of liver cancer coming back in people with high-risk HCC. You must be eligible for surgical removal of your tumor.
Badalona, BarcelonaAges 18 years+ - NCT07014371Recruiting
Comparing daily vs. every-other-day iron pills for iron deficiency anemia
This study compares taking iron pills every day versus every other day to treat iron deficiency anemia. The goal is to see which schedule is more effective and easier for patients.
BangkokAges 20 years+ - NCT07023172Recruiting
Study of Proline Plus Empagliflozin for Type 2 Diabetes
This study is testing a new medication called Proline Plus Empagliflozin to see how well it works for people with type 2 diabetes. It is for people who are starting this medication for the first time.
Xinyang, HenanAges 18 years+ - NCT07019454Recruiting
Custom stent graft for aneurysms near the kidneys
This study tests a doctor-modified stent graft to treat a type of abdominal aortic aneurysm (just above the kidneys). It may be an option if your aneurysm is large, growing, or causing symptoms, and standard devices aren't suitable.
Springfield, MassachusettsAges 18 years+ - NCT07016620Recruiting
Laser therapy for BPH after prior treatment
This study tests if laser therapy can help men whose BPH symptoms came back after a previous less invasive procedure. It's a way to treat the blockage without more major surgery.
Cleveland, OhioAges 40 years+ - NCT07014462Enrolling by invitationPhase 1
Venetoclax and dexamethasone for untreated AML
This trial tests a combination of two oral medicines (venetoclax and dexamethasone) for people with newly diagnosed AML who cannot have or choose not to have high-dose chemotherapy. The goal is to see if this gentler treatment is safe and tolerable.
Burlington, VermontAges 18 years+ - NCT07015112Recruiting
Medication check for older adults with multiple conditions
This trial tests a team-based approach to review and improve medication use for older adults (65+) who have three or more chronic conditions and are staying in an intermediate care hospital. The goal is to make sure your medicines are as safe and effective as possible.
Barcelona, BarcelonaAges 65 years+ - NCT07015567Recruiting
Treating complex PTSD in displaced people
This study tests a psychotherapy for people with complex PTSD who are refugees or asylum seekers. It aims to help reduce trauma symptoms using culturally adapted talk therapy.
Hamburg, Free and Hanseatic City of HamburgAges 17 years+ - NCT07020975Enrolling by invitation
Virtual reality for anxiety relief in infertile women
This trial tests whether virtual reality can help reduce anxiety in women with primary infertility. You would use a VR headset to experience relaxing scenes, and researchers will measure how your anxiety levels change.
Girne Kepuveia, KeryneiaAges 18–50 - NCT06997185Recruiting
Study on explaining cancer drug benefits and risks
This study looks at how to explain the benefits and risks of new cancer drugs in a way that is easier to understand. It helps researchers learn how to communicate better with patients like you.
Boston, MassachusettsAges 18 years+ - NCT04802707RecruitingPhase 2
Study drug for mitochondrial depletion disorder due to gene changes
This Phase 2 trial tests a treatment made from deoxynucleosides to help people with mitochondrial depletion disorder caused by certain gene changes. If you match the genetic diagnosis, the study may see whether the treatment improves symptoms or disease markers.
Montreal, QuebecAges 1 month–60 years - NCT05324475Recruiting
Nutritional supplement to support immunity and energy in older adults
This trial tests whether a safe nutrition supplement can help older adults with malnutrition maintain immune function and energy (mitochondrial function). It may support recovery during rehabilitation, but you must meet specific nutrition and health criteria.
Lausanne, SwitzerlandAges 75 years+ - NCT05518253RecruitingPhase 1
CAR-T treatment for CD70-positive advanced solid tumors
This trial tests a lab-made immune therapy (CAR-T) that targets a protein called CD70 found on some advanced cancers. It’s designed for people whose solid tumors have spread and no standard treatments have worked or weren’t tolerated.
Hangzhou, ZhejiangAges 18 years+ - NCT05677282RecruitingPhase 4
Single-dose antibiotics for sudden watery diarrhea
This trial compares rifaximin or azithromycin (both antibiotics) taken as a single dose, with loperamide to control symptoms. It’s for people with recent, watery diarrhea who can be treated and followed as an outpatient, to see which option works better and is safer.
DjiboutiAges 18–60 - NCT05976256Recruiting
Kinesio tape for new shoulder or chest injuries
This trial looks at whether kinesio tape (elastic therapeutic tape) helps pain and movement after a fresh shoulder or chest wall injury. It’s designed for certain types of rib, collarbone, or shoulder joint injuries when the injury happened very recently.
AmsterdamAges 18 years+ - NCT06621264Recruiting
Exercise study to improve walking in kidney and artery disease
This trial tests whether a supervised exercise program can help people with chronic kidney disease and peripheral artery disease walk better and feel stronger. It aims to improve mobility and quality of life.
Ferrara, ItalyAges 18–80
Hear when a new Treatment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for treatment?
- Yes. Clin2 currently lists 8,313 recruiting treatment studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a treatment trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a treatment trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.